What is the difference between Alzheimer's disease and dementia — and why does it matter?
Dementia is not a single disease — it is a broad clinical definition describing a progressive change in which cognitive or behavioral impairment begins to affect everyday life. It has over 200 distinct causes. Alzheimer's disease is the most common of those causes, defined specifically by the buildup of two proteins — amyloid and tau — that have toxic effects on neurons.
The distinction matters because the two terms are routinely conflated, yet treating them as synonyms obscures what is actually happening in a patient's brain. When neurologist Masud Husain explains the difference, he is also pointing to something clinically underappreciated: where in the brain the amyloid and tau pathology accumulates determines which symptoms appear first. If it builds up in regions associated with memory, memory loss is the earliest sign. If it accumulates in areas linked to motivation or behavior, those are the first symptoms to surface — long before memory is affected.
This reframing has real implications. Husain's research at Oxford's Dementia Research Group shows that people who develop apathy in older age have twice the chance of developing dementia in the next ten years compared to those with normal motivation levels. In other words, a behavioral change that looks like laziness or low mood may be a neurological early warning — one that most standard clinical assessments miss entirely. You can hear the full conversation on Listenly.
Key distinction
Dementia = the clinical syndrome (200+ causes, defined by cognitive or behavioral impairment that disrupts daily life). Alzheimer's disease = one specific cause of dementia, identified by amyloid and tau protein accumulation that is toxic to neurons. All Alzheimer's is dementia; not all dementia is Alzheimer's.
"For David, the effort of putting the music systems together was not worth the reward of being able to listen to something pleasurable — and in David's case, very few things were worth the effort."— Masud Husain, Habits and Hustle, Episode 579
About Masud Husain
Masud Husain
Co-lead, Dementia Research Group · Editor-in-Chief, Brain journal · Oxford University
Masud Husain is recognized as one of the world's leading neurologists in the fields of memory, motivation, and cognitive decline. He co-leads the Dementia Research Group at Oxford University — an institution he also attended himself — where his work bridges clinical neurology and fundamental brain science. He serves as editor-in-chief of Brain, one of the most authoritative and widely cited journals in neurology, a role that places him at the center of the field's most significant research. Unlike theorists working from models alone, Husain has spent decades studying real patients whose conditions illuminate how the brain actually breaks down — and what can be done about it. His clinical work with patients such as David, who lost all motivation following two nearly invisible strokes in the basal ganglia, directly informs his understanding of how dementia-related pathology manifests behaviorally before it ever affects memory. That patient-first perspective is precisely what makes his account of the Alzheimer's–dementia distinction authoritative rather than merely definitional.
See also
In a study conducted at Oxford, Dr. Husain and colleagues recruited university students across a spectrum of motivation levels and scanned their brains to understand what distinguishes apathetic individuals from highly motivated ones at a neurological level.
Beyond physical factors like exercise, sleep, and stress management, Dr. Husain identifies three psychosocial factors as equally important: maintaining a sense of purpose, staying socially connected, and continuing to engage in mentally stimulating activities.
Dr. Husain explains that high-performing individuals often maintain cognitive function longer because of greater cognitive reserve, coping strategies, and neurological resilience — but when the threshold is crossed, decline can appear steeper because the underlying pathology has been accumulating undetected for longer.